Archives
Biomechanical Coordination in Clathrin Endocytosis
2026-08-27
Wu and colleagues use multidimensional single-particle tracking to map rotational signatures of late-stage clathrin-mediated endocytosis in living cells. Their findings distinguish a broadly observed dynamin-associated in-plane twist from an actin-linked out-of-plane “swing,” showing that late-stage membrane remodeling is mechanically heterogeneous rather than governed by one obligatory motion.
Nitrocefin Assays for β-Lactamase Research
2026-08-27
Nitrocefin converts β-lactamase hydrolysis into a rapid yellow-to-red signal, supporting enzyme characterization, resistance profiling, and inhibitor screening. This practical guide connects assay setup and troubleshooting with the GOB-38 findings reported in Elizabethkingia anophelis research.
Self-Adaptive Nanocarriers for Pancreatic Cancer
2026-08-26
The ACS Nano study develops DATCPT, a pH/reactive oxygen species-responsive nanocarrier designed to expose tumor-binding groups, remodel pancreatic tumor extracellular matrix, and deliver camptothecin more deeply. Its significance lies in integrating drug release, matrix degradation, and anti-metastatic activity into one sequential delivery system for orthotopic pancreatic cancer.
Cytochalasin B: Actin Assay Workflows
2026-08-26
Cytochalasin B, also known as NSC 107658, provides a reversible way to perturb actin-dependent morphology, migration, cytokinesis, and uptake. This guide turns that mechanism into practical workflows with dose-finding, washout controls, orthogonal toxicity checks, and troubleshooting strategies for cytoskeletal research and drug discovery.
miR-196a and the MYC/TERT/NFκB Axis in EAC
2026-08-25
García-Castillo and colleagues identify miR-196a as a functional driver of esophageal adenocarcinoma aggressiveness, rather than only a marker of disease progression. Their experiments connect miR-196a to VCP loss, c-MYC accumulation, TERT induction, NFκB activation, epithelial-to-mesenchymal transition, and increased cell motility, providing several experimentally testable nodes for cancer research.
MRT68921: Selective ULK1/2 Kinase Inhibitor
2026-08-25
MRT68921 is a nanomolar dual ULK1/2 kinase inhibitor that blocks early autophagy signaling through ULK1-dependent effects on ATG13 phosphorylation and LC3 flux, according to the product information. Its strongest current use is controlled cellular pathway dissection, not therapeutic or in vivo application.
PA-Ψ-seq Maps Pseudouridine on Cellular and HIV-1 RNA
2026-08-24
Martinez Campos et al. introduce photo-crosslinking-assisted Ψ sequencing (PA-Ψ-seq), an antibody-based method for mapping pseudouridine residues across cellular and HIV-1 RNAs. Their results assign several cellular mRNA sites to PUS1, PUS7, or TRUB1/PUS4, while showing that pseudouridine on HIV-1 transcripts is unaffected by loss of these enzymes.
Dihydroartemisinin Research Workflows
2026-08-24
Build reproducible Dihydroartemisinin assays by controlling solvent handling, exposure design, and orthogonal readouts across parasite and mammalian-cell models. This guide translates antiplasmodial assay logic from a phebestin study into practical workflows for mTOR, inflammation, and psoriasis research without confusing compound-specific evidence.
Pravastatin Sodium: Assay Workflows & Applications
2026-08-23
Pravastatin sodium provides a practical, selective way to suppress cholesterol biosynthesis in macrophage, hepatocyte, and metabolic disease models. This guide connects dose design with transporter-aware cytotoxicity testing, helping researchers distinguish target engagement from nonspecific loss of cell function.
2',7'-Dichlorofluorescein Diacetate for ROS
2026-08-22
2',7'-Dichlorofluorescein diacetate is a cell-permeable fluorogenic probe for intracellular ROS measurement and general oxidative-stress profiling. Its fluorescent product reports integrated redox activity rather than a single reactive species, so controls and orthogonal validation are essential.
Norovirus Co-opts NINJ1 for Selective Protein Secretion
2026-08-22
Song et al. show that murine norovirus repurposes the membrane-rupture protein NINJ1 to release the viral immune-modulatory protein NS1, while still permitting broad damage-associated molecular pattern release. The study combines CRISPR screening, infection models, protein-interaction analysis, mutagenesis, and mouse experiments to define an unconventional secretion mechanism that is relevant to enteric viral pathogenesis.
Scalable iMSC-EV Manufacturing for Pulmonary Fibrosis
2026-08-21
Gong et al. developed a bioreactor-based platform that generates induced mesenchymal stem cells from extended pluripotent stem cells and produces extracellular vesicles at a scale relevant to translational research. The resulting iMSC-EVs retained key characteristics and therapeutic activity of primary MSC-EVs in a bleomycin-induced pulmonary fibrosis model, while addressing major manufacturing barriers such as donor variability and limited expansion.
GOB-38 in Elizabethkingia anophelis: Substrate Specificity
2026-08-20
The reference study characterizes GOB-38, a B3-Q metallo-β-lactamase from Elizabethkingia anophelis, and shows that its substrate range includes penicillins, multiple cephalosporin generations, and carbapenems. Recombinant expression, biochemical testing, genomic analysis, and co-culture experiments connect enzyme structure with clinically relevant resistance and raise the possibility that co-infecting bacteria may acquire carbapenem resistance.
CNQX Workflow for AMPA/Kainate Circuit Studies
2026-08-20
CNQX provides a practical way to separate AMPA/kainate-driven excitation from NMDA-dependent signaling in neuronal and autonomic circuit assays. This workflow connects receptor pharmacology with the cNTS–PVN cardiovascular study, emphasizing local delivery, matched controls, solution handling, and interpretation of negative results.
HRP Goat Anti-Mouse IgG (H+L) Antibody
2026-08-19
K1221 provides an HRP-labeled, affinity-purified goat polyclonal secondary antibody for detecting mouse-derived IgG in Western blotting, ELISA, IHC, and ICC. It should be paired with a validated mouse primary antibody and should not be treated as a universal reagent for non-mouse primaries, unvalidated tissue backgrounds, or applications requiring a non-HRP detection chemistry.
603 records 10/41 page Previous Next First page 上5页 678910 下5页 Last page